These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18252876)

  • 1. Therapies aim to boost "good" cholesterol.
    Mitka M
    JAMA; 2008 Feb; 299(5):509-10. PubMed ID: 18252876
    [No Abstract]   [Full Text] [Related]  

  • 2. Trial clouds use of niacin with a statin.
    Harv Heart Lett; 2011 Aug; 21(12):2. PubMed ID: 21991606
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapy and clinical trials: HDL-cholesterol and niacin therapy--past, present, and future.
    Virani SS; Ballantyne CM
    Curr Opin Lipidol; 2010 Apr; 21(2):165-6. PubMed ID: 20616632
    [No Abstract]   [Full Text] [Related]  

  • 4. Nicotinic acid and HDL-C reduction.
    S Afr Med J; 2005 Feb; 95(2):89. PubMed ID: 15751197
    [No Abstract]   [Full Text] [Related]  

  • 5. Insights from recent meta-analysis: role of high-density lipoprotein cholesterol in reducing cardiovascular events and rates of atherosclerotic disease progression.
    Negi S; Ballantyne CM
    J Clin Lipidol; 2010; 4(5):365-70. PubMed ID: 21122680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.
    Harikrishnan S; Rajeev E; Tharakan JA; Titus T; Ajit Kumar VK; Sivasankaran S; Krishnamoorthy KM; Nair K
    Indian Heart J; 2008; 60(3):215-22. PubMed ID: 19240310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The facts behind niacin.
    Hochholzer W; Berg DD; Giugliano RP
    Ther Adv Cardiovasc Dis; 2011 Oct; 5(5):227-40. PubMed ID: 21893559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Researchers still seek clinical benefit in raising levels of good cholesterol.
    Mitka M
    JAMA; 2012 Jan; 307(1):21-2. PubMed ID: 22215155
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ARBITER-2 : evidence that targeting HDL cholesterol slows atherosclerosis.
    Cardiovasc J S Afr; 2005; 16(1):61. PubMed ID: 15778778
    [No Abstract]   [Full Text] [Related]  

  • 11. HDL cholesterol--how do I raise my patients good cholesterol?
    Shaikh Q; Kamal AK
    J Pak Med Assoc; 2012 Jun; 62(6):623-4. PubMed ID: 22755358
    [No Abstract]   [Full Text] [Related]  

  • 12. What does the future hold for niacin as a treatment for hyperlipidaemia and cardiovascular disease?
    Ahmed MH
    J Cardiovasc Med (Hagerstown); 2010 Nov; 11(11):858-60. PubMed ID: 20686417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All at sea: new lipid-lowering drug trials continue to disappoint.
    Wierzbicki AS
    Int J Clin Pract; 2013 Jul; 67(7):595-8. PubMed ID: 23758438
    [No Abstract]   [Full Text] [Related]  

  • 14. Niacin: the only vitamin that reduces cardiovascular events.
    Wierzbicki AS
    Int J Clin Pract; 2011 Apr; 65(4):379-85. PubMed ID: 21401825
    [No Abstract]   [Full Text] [Related]  

  • 15. Niacin's role in the statin era.
    Brooks EL; Kuvin JT; Karas RH
    Expert Opin Pharmacother; 2010 Oct; 11(14):2291-300. PubMed ID: 20569085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Niacin and statin combination therapy for atherosclerosis regression and prevention of cardiovascular disease events: reconciling the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) trial with previous surrogate endpoint trials.
    Michos ED; Sibley CT; Baer JT; Blaha MJ; Blumenthal RS
    J Am Coll Cardiol; 2012 Jun; 59(23):2058-64. PubMed ID: 22520249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the road to better dyslipidemia outcomes.
    Hughes S
    Nurse Pract; 2009 Feb; 34(2):14-21; quiz 22. PubMed ID: 19155874
    [No Abstract]   [Full Text] [Related]  

  • 18. Is niacin ineffective? Or did AIM-HIGH miss its target?
    Nicholls SJ
    Cleve Clin J Med; 2012 Jan; 79(1):38-43. PubMed ID: 22219232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperlipidaemia and cardiovascular disease: low HDL-cholesterol as a therapeutic target in statin-treated patients: a role for nicotinic acid (niacin)?
    Choudhury RP
    Curr Opin Lipidol; 2010 Apr; 21(2):161-2. PubMed ID: 20616630
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical practice. Low HDL cholesterol levels.
    Ashen MD; Blumenthal RS
    N Engl J Med; 2005 Sep; 353(12):1252-60. PubMed ID: 16177251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.